Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 550

Showing 1-25 of 550 citing articles:

Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways
Xiang Wang, Xinxin Chen, Wenqian Zhou, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 708-722
Open Access | Times Cited: 304
FGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
Leigang Jin, Leiluo Geng, Lei Ying, et al.
Circulation (2022) Vol. 146, Iss. 20, pp. 1537-1557
Open Access | Times Cited: 131
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 107
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
Meng-ling Peng, Yu Fu, Chu-wen Wu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 81
6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
Shenglin Wu, Jinxiu Zhu, Guihai Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 77
CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes
Qiong Yuan, Yunwei Sun, Fan Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway
Wanqiu Zhang, Jinghua Lu, Yangyang Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 858-858
Open Access | Times Cited: 57
Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy
Fabiola Marino, Nadia Salerno, Mariangela Scalise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1132-1132
Open Access | Times Cited: 48
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Oke-Oghene Philomena Akpoveso, Emeka Emmanuel Ubah, Gideon Obasanmi
Antioxidants (2023) Vol. 12, Iss. 1, pp. 123-123
Open Access | Times Cited: 47
Mitophagy for cardioprotection
Allen Sam Titus, Eun‐Ah Sung, Daniela Zablocki, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 44
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review
Wencan Li, Xiang Liu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus
Xiu Mei, Kang Geng, Peng Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation
Maoxiong Wu, Jing Tan, Zhengyu Cao, et al.
Redox Biology (2024) Vol. 73, pp. 103184-103184
Open Access | Times Cited: 17
Predicting coronary heart disease in Chinese diabetics using machine learning
Cai-Yi Ma, Yamei Luo, Tianyu Zhang, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107952-107952
Closed Access | Times Cited: 15
KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy
Ioannis D. Kyriazis, Matthew Hoffman, Lea Gaignebet, et al.
Circulation Research (2020) Vol. 128, Iss. 3, pp. 335-357
Open Access | Times Cited: 100
The regulatory roles of p53 in cardiovascular health and disease
Hongbo Men, He Cai, Quanli Cheng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 5, pp. 2001-2018
Closed Access | Times Cited: 97
Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy
Daniela Ramaccini, Vanessa Montoya‐Uribe, Femke J. Aan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 95
Mitochondria-Associated Endoplasmic Reticulum Membranes in Cardiovascular Diseases
Peng Gao, Zhencheng Yan, Zhiming Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 94
HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes
Nian Wang, Heng Ma, Jing Li, et al.
Journal of Molecular and Cellular Cardiology (2020) Vol. 150, pp. 65-76
Closed Access | Times Cited: 90
Physical Exercise: A Novel Tool to Protect Mitochondrial Health
Daniela Sorriento, Eugenio Di Vaia, Guido Iaccarino
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 75
FGF1ΔHBS prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression
Dezhong Wang, Yuan Yin, Shu‐Yi Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 72
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 71
Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress
Xuemei Gu, Yujuan Shi, Xiaojun Chen, et al.
Phytomedicine (2020) Vol. 78, pp. 153319-153319
Closed Access | Times Cited: 70
Page 1 - Next Page

Scroll to top